Welcome to the 3rd Annual Non-Viral RNA Delivery Systems Summit!
Curated in collaboration with key opinion leaders and technical experts, the 3rd Non-Viral RNA Delivery Systems Summit returns as the only industry dedicated event uniting RNA companies to learn and hear about each other’s delivery platforms to overcome the field’s largest challenge of delivery.
Industry experts will navigate through presentations and interactive discussions to:
Supercharge development of innovative and novel non-viral delivery platforms beyond lipid nanoparticles to stay ahead of the curve and achieve targeted extra-hepatic delivery with Capricor Therapeutics, Vesigen Therapeutics & Replicate Biosciences
Achieve reduced toxicity and redosability of lipid nanoparticles through understanding novel compositions and immunogenic effects for safer RNA therapeutics with Corti Therapeutics & Tessera Therapeutics
Prevent rate-limiting endosomal escape through utilizing enhancer compounds for more potent and efficacious treatments with Sapreme Technologies & University of Connecticut
Optimize delivery platforms for large RNA payloads for successful delivery of gene therapies and vaccines to widen the landscape of treatable diseases with AstraZeneca, Sanofi & Yoltech Therapeutics
Accomplish successful translation of non-viral delivery platforms by addressing key challenges in the pre-clinical to clinical roadmap for accelerating therapeutics towards approval with Northeastern University, Beam Therapeutics & Takeda Pharmaceuticals